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Abstract. Non-medical use of prescription pain relievers (PPRs), heroin, and more recently 
fentanyl, continue to have major public health consequences in the United States. This article 
analyzes trends in PPR and heroin use, emergency department and hospital stays, substance 
use treatment services, and mortality to assess the relative impact of the opioid crisis on rural 
versus more urbanized counties in the United States. Our findings suggest that while more 
urbanized counties have had greater increases in opioid use, rural and less urbanized 
counties tended to be more negatively impacted than larger and non-rural counties. 
Disparities in service availability highlight the need for a serious discussion on how 
resources are allocated in counties that have lower tax bases. Based on these results, we 
conclude that rural and less urbanized counties can benefit from real increases in resources 
for substance use prevention and treatment services, including the expansion of prescribers 
trained to screen and treat opioid use. Understanding the unique challenges of rural and less 
urbanized counties may help decrease the disparity in consequences found in this study. 
 
 Keywords: rural-urban opioid use, rural services, morbidity, mortality, urbanicity 
 
The consequences of the non-medical use of prescription pain relievers (PPR), heroin, 
and more recently fentanyl, continue to be a major concern of public health experts across the 
United States.  These consequences include increases in the demand for opioid treatment 
(Jones, Campopiano, Galdwin, & McKance-Katz E., 2015;  Liebling et al., 2016; Wu, Zhu, & 
Swartz,  2016) and hospital services, (Coben et al., 2010; Milard, 2007; Neven et al., 2016;  
Owens, Barrett, Weiss, Washington, & Kronick, 2016), growing numbers of infants born with 
neonatal abstinence syndrome (Patrick, Davis, Lehmann, & Cooper, 2015),  and concerns 
over the rising rates of HIV and Hepatitis C, especially among individuals who transition 
from the non-medical use of prescription drugs to intravenous heroin use (Dunn et al., 2016; 
Klevens, Hu, Jiles, Holmberg, 2012; Rudd, Aleshire, Zibbell, & Gladden, 2016).  Though 
data from the National Survey on Drug Use and Health (NSDUH) show a decline in the use of 
PPRs from a high of 5.3 million individuals 12 and older in 2009 to 4.3 million individuals in 
2014 (Substance Abuse and Mental Health Services Administration [SAMHSA], 2015), 
researchers report that there has also been an increase in the incidence of prescription opioid 
use disorders (Han, Compton, Jones, & Cai, 2015).  During the same time period, past year 
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and past month use of heroin has more than doubled (126% and 162% increase respectively) 
(Center for Behavioral Health Statistics and Quality [CBHSQ], 2016a; Cicero & Kuehn, 
2014). 
 
Though some research suggests that PPR use may be lower in non-metropolitan and 
rural areas (Roman, Abraham, & Knudsen, 2011), these findings may conceal significant 
variation in use and consequences that may exist within urbanized, less urbanized, and 
completely rural non-metropolitan areas when these communities are dichotomized into rural 
and urban communities.  Further, by distinguishing communities by population and size of 
areas, there is potential for creative responses that are more consonant with the unique nature 
of rural communities (Brems, Johnson, Warner, & Roberts, 2006; Talebreza-May, Jensen, & 
Shay, 2017).  Examining and understanding the differences in the rate and consequences of 
PPR use across geographic areas is a critical part of advocating for qualitatively different 
services in terms of needs and delivery systems (Pullen & Oser, 2014).   
 
Background 
 
The opioid epidemic, driven primarily by the non-medical use of PPRs through 2014, 
has often been associated with increases in opioid use in rural settings (Van Gundy, 2006).  
This may be in part because of the data which show that chronic pain injury is more common 
in rural areas and that per capita sales of opioid prescriptions are higher in states with 
significant rural populations (Corso & Townley, 2016).  However, data also show that overall 
substance use in rural areas, including opioid use, is not significantly different from urban 
areas (Brooks, Mcbee, Pack, & Alamian, 2017) and may in fact be slightly lower than in more 
densely populated areas of the country; except for underage drinking and methamphetamine 
use, which is somewhat higher (Lambert, Gale, & Hartley, 2008), especially among youth and 
young adults (Khary & Rigg, 2015).   
 
Rural communities differ in many ways from urban communities, including higher 
levels of poverty and child poverty (Flurhaty, 2002) and social and cultural isolation (Lee, 
2016) in rural areas.  In addition, there are many factors that create challenges in providing 
substance use treatment services including limited access to providers willing to prescribe 
opioid agonist medications and limited service infrastructure (Pullen & Oser, 2014; Walley et 
al., 2008).  Individuals in rural communities may face additional hurdles ranging from a 
limited number of facilities (Corso & Townley, 2016) to geographic service isolation which 
requires reliance on family and friends for transportation (Faul et al., 2015; Humble, Lewis, 
Scott & Herzog, 2013; Pullen & Oser, 2014).  Many may place a higher priority on basic 
medical and dental care service needs than on treatment for drug use (Fortney, Burgess, 
Boswroth, Booth, & Kaboli, 2011).   Recent research has highlighted a number of themes, in 
addition to service availability, that can create barriers to substance use treatment in rural 
communities including access to technology that can support treatment services (Browne et al., 
2016) service costs, and stigma (Broffman et al., 2016).  Personal views of treatment for 
substance use and health care in general and a lack of anonymity can exacerbate how stigma 
and access issues affect health care decisions (CBHSQ, 2015). 
  
Given the increasing number of individuals with opioid use disorders and the disparity in 
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the capacities of counties to respond to this ongoing epidemic, there is value in assessing the 
relative impact on two of the more severe consequences of this epidemic, morbidity and 
mortality.  This article analyzes data from national survey systems by level of urbanization to 
provide a contextual understanding of how opioid use, specifically the misuse of prescription 
pain relievers (PPRs) and heroin, differentially affects populations at different levels of 
urbanization to better inform policy and program decisions to address service needs of 
individuals with opioid use disorders with particular attention to the implications for practice in 
rural settings.  The analysis was purposely limited to PPR and heroin during the period of 2002-
2014, in part, because of changes in the major survey on drug use and also to provide clarity to 
the analysis.  
 
Method 
 
We used data from national surveys on drug use and treatment services, administrative 
data on health care use, authorized prescribers, and morbidity and mortality related to PPR and 
heroin use.  Additionally, we were able to include data provided by Federal partners and online 
sources.  
 
Staff from the CBHSQ at the SAMHSA provided data on trends in past year PPR misuse 
from the National Survey on Drug Use and Health (NSDUH).  The NSDUH provides national 
and state-level estimates of the use of illicit drugs, including nonmedical use of prescription 
drugs, alcohol, and tobacco among civilian, noninstitutionalized populations aged 12 years and 
older in the United States.  Data for this study included the number and percentage of individuals 
who misused PPRs for the period 2002-2014.  Data from subsequent years was not included in 
this analysis as the NSDUH was redesigned in 2015 and the data were not comparable. 
 
Data from the Behavioral Health Treatment Locator files (found at 
https:/findtreatment.samhsa.gov) were downloaded and analyzed to identify substance use 
treatment and opioid treatment capacity across the United States.  These files use data from the 
National Survey of Substance Abuse Treatment Services (N-SSATS), an annual survey of public 
and private treatment facilities, including opioid treatment programs, that collects information on 
facility characteristics, client counts by service type, and licensure and accreditation from 
facilities in the United States (SAMHSA, 2014).  
 
The Drug Enforcement Administration provided de-identified administrative data on 
physicians granted waivers to prescribe buprenorphine outside of opioid treatment programs in 
February of 2016.  
 
We used the faststats online tool provided by the Agency for Healthcare Quality and 
Research (AHRQ) Healthcare Cost and Utilization Project (HCUP) to extract the number of PPR 
and heroin-related emergency department visits and inpatient stays.  HCUP includes a number of 
administrative datasets on inpatient stays, ambulatory care services, and emergency department 
visits.  We used data from the Nationwide Emergency Department Sample (NEDS) (AHRQ, 
2016) and from the Nationwide Inpatient Sample (NIS) (Houchens, Ross, Elixhauser, & Jian, 
2014) for the years 2005-2014.   
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The total the number of opioid-related emergency room visits and inpatient stays in 
HCUP was calculated using the following opioid-related diagnostic codes from the International 
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) (DHHS, 2015)*:  
 
• 304.00 – 304.02: Opioid type dependence (unspecified; continuous; episodic); 
 
• 304.70 – 304.72: Combinations of opioid type drug with any other drug dependence 
unspecified; continuous; episodic); 
 
• 305.50 – 305.52: Opioid abuse (unspecified; continuous; episodic); 
 
• 965.00 – 965.02; 965.09: Poisoning by opium (alkaloids), unspecified; heroin; 
methadone; other opiates and related narcotics; 
 
• E850.0 – E850.2: Accidental poisoning by heroin; methadone; other opiates and 
related narcotics; 
 
• E935.0 – E935.2: Heroin, methadone, other opiates and related narcotics causing 
adverse effects in therapeutic use; and 
 
• E940.1: Opiate antagonists causing adverse effects in therapeutic use. 
 
IDC-9-CM diagnosis codes related to opioid dependence or abuse “in remission” were 
not used to identify opioid-related hospital use because remission does not indicate active 
periods of use. 
 
For mortality, PPR and heroin-involved drug poisoning deaths for the years 1999 through 
2016 were extracted from the Multiple Cause of Death (MCD) files released by the National 
Center for Health Statistics (NCHS) in 2017a on the Centers for Disease Control and 
Prevention’s Wide-ranging Online Data for Epidemiologic Research (CDC/WONDER) online 
information system.  The MCD files contain mortality and population counts for all U.S. counties 
based on death certificates for U.S. residents compiled from data provided by the 57 vital 
statistics jurisdictions through the Vital Statistics Cooperative Program.  Each death certificate 
contains a single underlying cause of death but also can contain up to twenty additional 
(multiple) causes as well as demographic data. 
 
Drug poisoning deaths were identified using the International Classification of Diseases 
(ICD), 10th Revision (WHO, 1992).  Drug poisoning deaths were selected using underlying cause 
of death ICD-10 codes X40-X44, X60-64, X85, and Y10-Y14.  Then we used ICD-10 codes 
T40.2 to T40.4 and T40.6 to identify drug-poisoning deaths involving PPRs.  Drug-poisoning 
deaths involving to heroin, including opium, were identified using ICD-10 codes T40.0 and 
T40.1. 
 
 
* HCUP transitioned to the 10th edition of ICD (ICD-10-CM) in 2015, another reason for restricting this analysis to 
2014 and earlier. 
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Data Analysis 
 
Past Year Use of PPR and Heroin by Level of Urbanization   
 
To estimate the number of past year users by urbanicity, we utilized generated counts and 
percentages provided by CBHSQ for the years 2002 to 2014 using the 2003 rural-urban 
continuum codes, also known as the Beale codes, developed by the U.S. Department of 
Agriculture (CBHSQ, 2016b).  This provided three metro (Large, Medium, and Small) and three 
non-metro (Urbanized, Less Urbanized, and Completely Rural) levels of urbanization. 
 
Substance Abuse Facilities, Substance Abuse Facilities with Opioid Treatment Programs, 
Number of Physicians Holding Waivers to Prescribe Buprenorphine, and Number of 
Drug Poisoning Deaths Related to Prescription Pain Relievers, by Level of Urbanization 
 
We analyzed the number, percentage, and where appropriate the rate per hundred thousand 
across all 3,141 counties in the United States, by level of urbanization which is based on whether 
a county lies within a metropolitan statistical area (MSA), its population size, and whether it 
contains an urban population cluster. An MSA contains a core urban area of 50,000 population or 
more.  This analysis uses the NCHS classification noted above (Ingram, & Franco, 2014) with the 
following six levels of urbanization, in decreasing order of population size: 
 
• Large central metro — Counties in MSAs of 1 million or more population that: contain 
the entire population of the largest principal city of the MSA, or their entire population 
contained in the largest principal city of the MSA, or contain at least 250,000 inhabitants 
of any principal city of the MSA. 
 
• Large fringe metro — Counties in MSAs of 1 million or more population that did not 
qualify as large central metro counties. 
 
• Medium metro — Counties in MSAs with populations of 250,000 to 999,999. 
 
• Small metro — Counties in MSAs with populations less than 250,000 but greater than 
50,000; 
 
• Micropolitan — Counties that contain one or more urban clusters (An urban cluster is a 
small version of an urbanized area with 2,500–49,999 inhabitants.); and 
 
• Non-core — Non-metropolitan counties that did not qualify as micropolitan. This 
category is what we refer to as the most rural areas. 
 
Opioid-Related Emergency Department Visits and Inpatient Hospital Stays 
 
 The number of opioid-related emergency department visits and inpatient hospital stays, 
which is calculated from HCUP county level data, is similar to the NCHS categories except it 
reports five categories, large central metro, large fringe metro, medium metro, small metro, 
micropolitan, and non-core, instead of the six above. 
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   The data show that as urbanization decreases, the number of counties in the 
category classified as the most rural increases, with 42% of counties (1,333).  Fifteen 
percent of the United States population (46 million) live in rural areas, and 6% of the 
total population (19 million) are in the most rural areas. In terms of land area, the most 
rural counties account for 53% of the national total, with an additional 19% in less rural 
counties. The average area of counties tends to increase with less urbanization to an 
average of 1,506 square miles for very rural counties, and the average county 
population density decreases from 1,318 persons per square mile in large central 
metropolitan areas to 9.4 in the most rural areas. 
 
Results 
 
Past-year PPR use has been decreasing nationally since 2006 and, over time, past year 
PPR use has generally been lower among non-metropolitan communities and lowest among 
completely rural communities. (see Table 1).  By 2014, all county types saw a relative decrease 
in the percent of past year use except urbanized non-metropolitan counties which saw a 2.3% 
relative increase from 2002 in the percent of reported past year PPR use.  Completely rural 
counties saw the largest relative decrease in percent of past year use if PPRs (-42.07 %).    
 
Table 1 
  
Percent of Past Year Nonmedical Use of Prescriptions Opioid Analgesics among Persons Aged 
12 or Older by Level of Urbanization, 2002-2014 
 
       Metro             Non-Metro  
                            United           Large            Medium           Small                                Less             Completely 
   Year              States       > 1 Million     (250k to 1 M)    <250k                 Urbanized       Urbanized           Rural 
   2002                   4.67               4.56                4.96                 5.70                  4.58                3.69                 3.95 
   2003                   4.91               4.86                5.18                 5.17                  5.30                4.35                 2.37 
   2004                   4.68               4.38                5.27                 5.26                  4.94                4.41                 4.14 
   2005                   4.86               4.76                5.52                 4.17                  5.51                4.36                 3.76 
   2006                   5.14               5.10                5.68                 5.01                  5.26                4.18                 5.30 
   2007                   5.05               4.96                5.04                 5.30                  5.77                5.19                 3.76 
   2008                   4.77               4.73                4.90                 5.56                  4.39                4.33                 3.38 
   2009                   4.94               4.81                5.26                 5.47                  5.15                4.36                 3.98 
   2010                   4.83               4.81                4.94                 5.21                  4.94                4.40                 3.03 
   2011                   4.33               4.14                4.84                 5.11                  4.12                3.52                 3.00 
   2012                   4.80               5.00                4.78                 4.81                  4.46                4.09                 2.63 
   2013                   4.22               4.19                4.27                 4.43                  4.54                3.90                 3.50 
   2014                   3.90               3.87                3.92                 4.38                  4.69                3.10                 2.29 
Rel % Change1  
(2002-2014)       -16.59           -15.08             -20.96              -23.17                  2.30             -16.07             -42.07 
1 Difference statistics are based on non-rounded percentages.        
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 
2002-2014.  
 
 
Past year heroin use, though still a small percentage of drug use in the United States, 
doubled nationally from 0.17 % in 2002 to 0.34 % in 2014 (Table 2).  Increases were seen 
across all county types except completely rural counties which saw a decrease from 0.3% in 
6
Contemporary Rural Social Work Journal, Vol. 11 [2019], No. 1, Art. 7
https://digitalcommons.murraystate.edu/crsw/vol11/iss1/7
 
 
 
 
2002 to 0.1% in 2014 (a -48.33 relative percent change).  This may be because there is a much 
smaller market for heroin in less urbanized and completely rural counties compared to more 
urbanized counties.  Indeed, past year use more than doubled in metro areas with a three-fold 
relative percent change in small metropolitan counties (206.94 %).  Urbanized non-
metropolitan and less urbanized non-metropolitan counties saw much smaller increases with 
(relative percent changes of 14.71% and 4.51 % respectively between 2002 and 2014).   
 
Table 2    
 
Percent Past Year Heroin Use Among Persons Aged 12 or Older, by County Type, 2002-2014 
 
Metro         Non-Metro  
            United           Large          Medium           Small                Less         Completely 
Year                                  States       >1 Million    (250k to 1 M)    <250k         Urbanized       Urbanized           Rural 
2002   0.17       0.18   0.22          0.12    0.14  0.11      0.03 
2003   0.13       0.19   0.05          0.07    0.08  0.07      0.04 
2004   0.17       0.17   0.16          0.16    0.21  0.11      0.00 
2005   0.16       0.17   0.14          0.16    0.09  0.16      0.01 
2006   0.23       0.28   0.20          0.13    0.22  0.12      0.01 
2007   0.15       0.15   0.12          0.21    0.16  0.15      0.14 
2008   0.18       0.19   0.25          0.13    0.12  0.07      0.07 
2009   0.23       0.23   0.31          0.24     0.13  0.06      0.11 
2010   0.24       0.25   0.31          0.09    0.33  0.18      0.05 
2011   0.24       0.31   0.15          0.16    0.26  0.09      0.01 
2012   0.26       0.26   0.25          0.39    0.22  0.20      0.00 
2013   0.26       0.30   0.23          0.16    0.19  0.22      0.37 
2014   0.34       0.36   0.44          0.38    0.16  0.12      0.01 
Rel % Change 
Change1 (2002-2014)    100.79         100.11              101.81            206.94              14.71                  4.51          -48.33 
1 Difference statistics are based on non-rounded percentages.  
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 
2002-2014. 
 
Nationally, substance use treatment facilities, particularly opioid treatment program (OTP) 
facilities tend to be more available in in metropolitan counties than in less urbanized counties. 
Table 3 shows that one in ten large central metropolitan counties are without substance use 
treatment facilities while more than half (55 %) of non-core counties are without substance use 
treatment facilities.  The percentage of substance use facilities is relatively similar across large 
fringe, medium metropolitan, small metropolitan, and micropolitan counties (between 72% and 
76%).  The disparity in treatment facilities is most apparent when we looked at the number of 
counties with and without OTPs.  Eighty-eight percent of large central metropolitan counties have 
facilities with opioid treatment programs while micropolitan counties and non-core counties have 
a limited number of OTPs (9% and 1% respectively).  Although more than non-metropolitan 
counties, large fringe, medium, and small metropolitan counties have many fewer OTP facilities 
than large central counties (30%, 35%, and 24% respectively). As a result, more rural 
communities have no programs that can provide medications such as methadone or buprenorphine 
to intervene with individuals with opioid use disorders and individuals with opioid use disorders 
will have to travel long distances or do without medication-assisted treatment as an option. 
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Table 3 
 
Availability of Substance Use Treatment Facilities and Opioid Treatment Programs by Level 
of Urbanization, 2016 
 
                 Num (%) of Counties  Num (%) of Counties 
    Total Number            Without Substance Use    Without Opioid  
     Of Counties              Treatment Facilities Treatment Programs 
Large Central Metro          68           7 (10%)            8 (12%) 
Large Fringe Metro        368         88 (24%)        259 (70%) 
Medium Metro               373       100 (27%)        242 (65%) 
Small Metro         358       100 (28%)        267 (75%) 
Micropolitan (non-metro)              641       157 (24%)        586 (91%) 
Non-Core (non-metro)     1,333       728 (55%)      1,321(99%) 
United States      3,141    1,180 (38%)      2,683 (85%) 
Sources: Data on facilities from the Substance Abuse and Mental Health Services Administration. National 
Survey of Substance Abuse Treatment Services information on the Behavioral Health Treatment Services Locator, 
available at https://findtreatment.samhsa.gov/ accessed on February 10, 2016; county levels of urbanization from 
the National Center for Health Statistics classification. 
 
One strategy to address the shortage of OTPs has been to expand access to medications 
such as buprenorphine within private medical practices.  With the passing of the Drug Addiction 
Treatment Act of 2000 (DATA, 2000), physicians who receive specialized training could request 
a waiver to allow them to dispense buprenorphine from their medical office.  However, a recent 
study found that there continue to be significant gaps at the state and national level between the 
need for providers who can dispense buprenorphine and the current capacity.  We found these 
gaps to be much more pronounced when examining the differences by level of urbanization.  All 
of the large central metropolitan counties had more than five doctors holding waivers to dispense 
buprenorphine while fewer than 340 (2%) of non-core (non-metropolitan) counties had more than 
five physicians holding waivers.  Non-core counties also had the largest percentage of counties 
with no doctors holding a waiver for dispensing buprenorphine (72%).  Interestingly, micropolitan 
counties had the highest percentage (52%) of counties with between 1 and 5 doctors holding 
buprenorphine waivers (Table 4).  
 
Nationwide, between 2005 and 2014, the annual rate of opioid-related emergency 
department visits increased from 89.1 to 177.7 visits per 100,000.  Emergency department data, 
disaggregated by level of urbanization, show that small metropolitan and rural counties had the 
lowest rates of opioid-related visits in 2005 but these rates more than doubled by 2014 (70.1 to 
155.0 per 100,000 and 71.9 to 146.5 per 100,000 respectively).  The rate of emergency 
department visits also had more than doubled in medium metropolitan counties between 2005 
and 2014 (93.0 to 203.6 visits per 100,000) (Figure 1) (AHRQ, 2017a). 
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Table 4 
 
Number and Percent of Physicians Waived to Dispense Buprenorphine by level of 
Urbanization, 2016 
 
      Number and Percent of Counties with Waived Physicians 
             Number of   No Waived 1-5 Waived 5 or more 
              Counties  Physicians  Physicians Physicians 
Large Central Metro       68        0 (  0%)      0 ( 0%)       68 (100%) 
Large Fringe Metro     368      86 (23%)  107 (29%)     175 (48%) 
Medium Metro      373     107 (29%)    86 (23%)     180 (48%) 
Small Metro      358     113 (32%)  103 (29%)     142 (40%) 
Micropolitan (non-metro)     641     219 (34%)  332 (52%)       90 (14%) 
Non-Core (non-metro)  1,333     964 (72%)  340 (26%)       29 (2%) 
United States   3,141               1,489 (47%)  968 (31%)     684 (22%)  
Sources: Data on physicians from the Drug Enforcement Administration, unpublished data as of February 16, 
2016; county levels of urbanization from the National Center for Health Statistics classification. 
 
From 2005 to 2014, the annual rate of opioid-related hospital inpatient stays increased by 
64.2% nationwide.  During this period, medium metropolitan (83%) and large fringe (61%) 
counties saw the largest increases in rates opioid-related hospital stays followed by rural (57%) 
and small metropolitan (54%) counties.  By contrast, large central metropolitan counties saw an 
increase of 21% in the number of opioid-related hospital stays (Figure 2) (AHRQ, 2017b). 
 
 
 
Source:  Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP),  
Nationwide Emergency Department Sample (NEDS). Downloaded from https://www.hcup-
us.ahrq.gov/faststats/OpioidUseServlet on February 16, 2017.  
 
Figure 1. Opioid-Related Emergency Department Visits by Patient Location, 2005-2014 
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Source:  Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP), 
National (Nationwide) Inpatient Sample (NIS). Downloaded from https://www.hcup-
us.ahrq.gov/faststats/OpioidUseServlet on February 16, 2017.  
 
Figure 2. Opioid-Related Inpatient Stays by Patient Location, 2007-2014 
 
Figures 3 and 4 show national trends in drug-poisoning deaths involving PPR and heroin 
disaggregated by level of urbanization.  Figure 3 shows the trends in drug poisoning deaths 
involving PPR.  The data show that, except for large central counties which experienced less 
than a fifty percent increase (46%), counties across the United States experienced between a 
three and six-fold increase in the number of drug poisoning deaths related to POA.  Non-core 
counties experienced the largest increase (542%) in drug-poisoning deaths from 1.2 to 7.7 deaths 
per 100,000.  Figure 4 shows that drug poisoning deaths involving heroin rose sharply across all 
levels of urbanization in the past five years, though non-core counties consistently had lower 
rates of heroin-involved drug poisoning deaths compared to more urbanized counties (0.1 to 1.7 
deaths per 100,000).   
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Source: Centers for Disease Control and Prevention/National Center for Health Statistics. Multiple Cause of Death 
1999-2013 on CDC WONDER Online Database, released 2015.  Extracted by ONDCP on January 26, 2016. 
 
Figure 3. Drug Poisoning Death Rates Involving Opioid Analgesics by Level of Urbanization, 
1999  ̶  2014 (Includes ICD-10 Codes T40.2 to T40.4 and T40.6) 
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 Source:  Centers for Disease Control and Prevention/National Center for Health Statistics. Multiple 
Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Extracted by ONDCP 
on January 26, 2016. 
 
Figure 4. Drug Poisoning Death Rates Involving Heroin by Level of Urbanization, 1999-2014 
(Includes ICD-10 Codes T40.0 and T40.1 and includes Opium) 
 
 
Discussion 
 
 This study found that PPR use has declined and heroin use has increased nationally 
during the period 2002-2014, except in non-metro areas, where rates in 2014 were similar to 
rates in 2002.  This may indicate an absence of any significant market for heroin in rural 
communities.  Although the level of PPR and heroin use is not substantially different for rural 
and urban areas, the consequences of drug use in terms of morbidity and mortality tended to be 
larger in smaller metropolitan and rural areas.  Smaller and very rural communities have many 
fewer resources and are at a distinct disadvantage in terms of providing access to comprehensive 
and high-quality prevention and treatment services.  Substance use disorders are often complex 
health conditions that can include co-morbid health, mental health, and social issues.  Rural 
counties experience comparatively low educational achievement, low employment and 
underemployment, high poverty, and access challenges in term of geographic isolation, and high 
levels of stigma in terms of accessing health care.  Rural counties also are likely to experience 
significant stressors on public health and public safety systems as a result of higher rates of 
motor vehicle crashes, sexually transmitted diseases and blood borne viruses such as hepatitis C, 
fetal alcohol syndrome.   
 
 These findings underline an urgent need to expand services in rural communities to 
address resource limitations.  This includes expanding the number of physicians with DATA 
2000 waivers, and developing and deploying a well-trained and culturally competent workforce 
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with specific skills in treating opioid use disorders.  One strategy used in the past is to integrate 
medical practitioners and social workers with treatment expertise into Federally Qualified Health 
Centers (Corso & Townley, 2016).  Another strategy utilized in other high need areas is to use 
loan repayment programs to incentivizing practitioners to join the National Health Service Corps 
and long-term deployment of United States Public Health Officers.  Expanding these programs 
into rural community health centers could rapidly expand capacity in rural counties.   
 
 State and local governments also may want to invest in tele- and video-health 
technologies that may serve as a bridge to treatment where no facilities exist (Gates & Alberta, 
2016; Rooke, Gates, Norberg, & Copeland, 2014).  Expanded use of technology also may 
address the stigma that exists in rural communities where confidentiality is limited and 
practitioners may be challenged to maintain the boundary between professional practice and 
being a member of the community (Brems, Johnson, Warner & Roberts, 2006; Humble, Lewis, 
Scott, & Herzog, 2013).  Additionally, building formal and informal structures for consultation 
such as Project ECHO where physicians and social workers can connect to specialists to support 
and advance their practice and improve service access (Brems, Johnson, Warner & Roberts, 
2006; Humble, Lewis, Scott, & Herzog, 2013; Corso & Townley, 2016) and may help address, in 
part, the structural barriers to enhanced training for rural social work practitioners.   
 
 Expanding telehealth and teleconsultation services may address some of the need in 
rural areas.  It is not, however, a panacea for the lack of services that are local and culturally 
relevant in terms of norms, communication styles, and values.  Research by Oser and Harp 
(2015) found that when clients received treatment in a socio-cultural context unfamiliar to them 
due to lack of access to local care, geographic discordance, they were more likely to experience 
relapse and incarceration and less likely to be attending 12-step support groups or to have 
received referrals for continued care in their home community.  Given the documented costs to 
the individual and the community of relapse and continued drug use, the failure to allocate 
resources to expand treatment in geographically isolated areas appears short-sighted. 
  
This analysis is subject to a number of limitations and thus, care should be taken when 
interpreting findings.  First, the data in this study draw from a number of different data systems 
and data are not always reported for the same year time span, though there is overlap across 
significant periods of time.  For example, data on drug poisoning deaths cover the years 1999 to 
2014 while data on drug use cover the years 2002 to 2014.  Second, data that permits comparison 
by levels of urbanization are scarce and often use different strategies for identifying level of 
urbanization.  In the present study, data from NSDUH utilize Beale codes for classifying level of 
urbanization while estimates for treatment services, hospital visits, and drug overdose deaths related to 
PPR and heroin are consistent with NCHS’s classification of urban and rural counties.  Nevertheless, 
there is significant similarity across each of these continuums.   
 
Third, self-reported data such as NSDUH depend upon the veracity and accuracy of the 
individual respondent, which may lead to under or over-reporting of use.  The NSDUH utilizes a 
variety of methods to increase the accuracy of self-reported behavior, including the use of audio 
computer-assisted self-interviews and confidentiality agreements with respondents (Gfroerer, 
Everman, & Chromy, 2002).  Fourth, NSDUH does not include institutionalized populations 
such as those found in prisons, jails, treatment facilities, or individuals who are homeless.  It also 
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does not capture active duty military.  Consequently, our estimates of past-year users of PPR and 
heroin may not be generalizable to some segments of the U.S. population and the true number of 
users and their impact urban and rural counties may be different from the numbers presented in 
our study.     
 
Finally, the NEDS contains event-level records and there are no unique patient 
identifiers.  Individuals who visit an ED more than one time a year may be counted multiple 
times in NEDS.   Thus, the rate of ED visits may over-represent individuals who are more likely 
to have adverse consequences to opioid use.  Fourteen percent of the records are missing ED 
charges because there was no ED admission.  This leads to undercounting of opioid-related ED 
visits, regardless of level of urbanization (AHRQ, 2017a).  Finally, variability in reporting of 
specific drugs involved in drug-poisoning deaths may vary by state or jurisdiction, and poly-
substance use among decedents precludes drawing conclusion from information based on single 
drugs or drug subsets. 
 
Even with these limitations, arraying the available information on ED, inpatient, and drug 
poisoning death rates by level of urbanization provides valuable insight into what rural areas 
might be experiencing compared with more urbanized communities.   Despite relatively 
comparable levels of PPR use and markedly lower levels of heroin use, rural and less urbanized 
communities experience disproportionate consequences in terms of emergency and inpatient 
services use and drug poisoning deaths.  The disparity in service availability to treat opioid use 
disorders point to a need for expanding prevention programming, access to addiction 
professionals and medication-assisted treatment, including office-based providers, in more rural 
communities.  There are currently a number of efforts underway to increase training for 
prescribers in the use evidence-based screening and assessment practices and the use of 
prescription opioid analgesics, alternative pain management strategies, and the use of databases 
to review patient history prior to prescribing controlled substances (CDC, 2013); Franklin et al., 
2015; ONDCP, 2011).  Expanding these efforts into semi-rural and rural communities can 
provide additional tools to identify and support patients who are at-risk for or who have an 
opioid substance use disorder.  Taking into account the unique challenges experienced by rural 
and less urbanized communities may serve to decrease the disparate consequences of the opioid 
epidemic found in this study.  
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